Back
ESC Premium Access

Trends in indications and outcome in thrombolytic therapy: a retrospective single center study

Session: Cardiovascular pharmacotherapy
Topic: Cardiovascular Pharmacotherapy
Speaker: Doctor M. Engelen (Leuven, BE)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Matthias M Engelen

University Hospitals (UZ) Leuven, Leuven (Belgium)
0 follower

6 more presentations in this session

Research Network in Africa (RNA): quality assessment of antihypertensive generic drugs in 10 African countries

Speaker: Doctor D. Macquart de Terline (Paris, FR)

Access
Abstract
Like
Thumbnail

Clinical pharmacology of AZD9977, a novel, selective mineralocorticoid receptor (MR) modulator without K+-sparing properties

Speaker: Doctor A. Whittaker (Gothenburg, SE)

Access
Abstract
Like
Thumbnail

Impact on the prognosis of treatment administrated in the daily clinical practice to patients with myocardial infarction with non-obstructive coronary arteries.

Speaker: Doctor J. Lopez-Pais (Santiago de Compostela, ES)

Access
Abstract
Slides
Like
Thumbnail

Cardioprotective anti inflammatory effects of empaglifozin in doxorubicin induced cardiotoxicity: the role of leukotriene B4 and interleukin 1

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Risk of qtc interval prolongation among cancer patients treated with tyrosine kinase inhibitors

Access
Slides
Like
Thumbnail

Access the full session

Cardiovascular pharmacotherapy

Speakers: Doctor M. Engelen, Doctor D. Macquart de Terline, Doctor A. Whittaker, Doctor J. Lopez-Pais, Doctor N. Maurea
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources